Eye Disease Clinical Trial
Official title:
Analysis of Human Tear Proteins: A Pilot Study to Describe the Tear Film Proteome of Patients Undergoing Ophthalmic Examination.
Verified date | October 2012 |
Source | University of Colorado, Denver |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film from diseased and non-diseased patients. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.
Status | Terminated |
Enrollment | 63 |
Est. completion date | September 2011 |
Est. primary completion date | September 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 18 years of age and older - able to cooperate with tear sample collection - provide written informed consent Exclusion Criteria: - special populations (children, pregnant or lactating females, prisoners, etc) - refusal to sign sudy consent |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | Rocky Mountain Lions Eye Institute | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Plan Prospective Research | Pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion. | Throughout study participation | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02500862 -
Characterization of Potential Biomarkers of Eye Disease and Vision
|
||
Completed |
NCT02003547 -
A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01693315 -
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
|
Phase 2 | |
Recruiting |
NCT02321189 -
The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness
|
N/A | |
Completed |
NCT00073099 -
Digital Photography to Evaluate Dry Eye
|
N/A | |
Completed |
NCT00678860 -
Validation of Computerized Vision-Targeted Quality-of-Life Questionnaires
|
N/A | |
Completed |
NCT00957190 -
The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial)
|
Phase 4 | |
Active, not recruiting |
NCT00386906 -
Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma
|
Phase 1 | |
Completed |
NCT00001737 -
Cyclosporin Implant to Treat Uveitis
|
Phase 1 | |
Completed |
NCT04912622 -
RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders
|
N/A | |
Recruiting |
NCT02321176 -
Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood
|
N/A | |
Completed |
NCT00591110 -
Project inCharge: Increasing the Rate of Comprehensive Eye Care Utilization by Older African Americans Through Community-Based Eye Health Education Program
|
N/A | |
Unknown status |
NCT00649766 -
Tailored Messages to Increase Eye Examination Behavior
|
N/A | |
Completed |
NCT02851251 -
Multicenter Neonatal Eye Disease Screening in China
|
||
Active, not recruiting |
NCT01648452 -
CNTF Implants for CNGB3 Achromatopsia
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT01396967 -
Trying a New Device for Performing Capsulorhexis in Cataract Surgery Surgery
|
Phase 1 | |
Completed |
NCT00270647 -
Physicians' Health Study II
|
N/A | |
Completed |
NCT00001224 -
Analysis of Eye Tissue
|
N/A | |
Completed |
NCT00473278 -
Analysis of Human Tear Proteins in Children
|
N/A | |
Recruiting |
NCT02821767 -
Natural History, Pathogenesis, and Outcome of Ocular Disorders
|